-
Je něco špatně v tomto záznamu ?
Combination of plant phenolics and isoquinolinium alkaloids protects gingival fibroblast and improves post-extraction healing after lower third molar extraction
K. Chytilova, A. Galandakova, K. Valentova, P. Tvrdy
Jazyk angličtina Země Česko
Typ dokumentu randomizované kontrolované studie, časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
34617520
DOI
10.5507/bp.2021.055
Knihovny.cz E-zdroje
- MeSH
- alkaloidy * farmakologie MeSH
- cyklooxygenasa 2 farmakologie MeSH
- fenoly farmakologie MeSH
- fibroblasty metabolismus MeSH
- hojení ran MeSH
- interleukin-6 MeSH
- kvalita života MeSH
- lidé MeSH
- lipopolysacharidy farmakologie MeSH
- molár třetí * chirurgie metabolismus MeSH
- reaktivní formy kyslíku metabolismus farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
AIMS: The effect of polyphenolic fraction of Lonicera caerulea (PFLC) and alkaloid fraction of Macleaya cordata (AFMC) mix on the production of inflammatory mediators in human gingival fibroblasts pretreated with lipopolysaccharide (LPS) was investigated. In addition, protective effects of mucoadhesive paste containing combination of PFLC and AFMC (0.05% and 0.01%, respectively; n=15, Group A) and placebo (n=15, Group B) were evaluated in patients after surgical extraction of lower third molars. METHODS: Gingival fibroblasts were pre-treated with LPS (10 μg/mL; 24 h) and PFLC/AFMC (25/0.25; 50/0.25; 100/0.25; 25/0.5; 50/0.5; 100/0.5 μg/mL) in serum-free medium was applied for 4 h. Then the interleukin-6 (IL-6), reactive oxygen species (ROS) generation, level of intracellular glutathione (GSH) and expression of cyclooxygenase-2 (COX-2) were evaluated. The study was a 6-day, single-center, randomized, double-blind and placebo-controlled trial consisting of two parallel treatment arms. A modified Oral health impact profile questionnaire including both general oral condition and extraction related questions, was used to evaluate the oral condition and other changes before (day 0) and on the days 1, 3 and 6 after surgical extraction. RESULTS AND CONCLUSION: The combination of PFLC with AFMC caused a reduction of ROS generation, reduced IL-6 production and suppressed the expression of COX-2. In group A the paste treatment contributed to improvement of oral health-related quality of life. Topical application of PFLC and AFMC into the extraction wound improved post-extraction site wound healing probably by antioxidant and anti-inflammatory mechanisms.
Department of Oral and Maxillofacial Surgery University Hospital Olomouc Czech Republic
Institute of Microbiology Czech Academy of Sciences Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23008954
- 003
- CZ-PrNML
- 005
- 20230807083255.0
- 007
- ta
- 008
- 230707s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2021.055 $2 doi
- 035 __
- $a (PubMed)34617520
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Chytilová, Karin $u Department of Oral and Maxillofacial Surgery, University Hospital, Olomouc, Czech Republic $7 xx0304254
- 245 10
- $a Combination of plant phenolics and isoquinolinium alkaloids protects gingival fibroblast and improves post-extraction healing after lower third molar extraction / $c K. Chytilova, A. Galandakova, K. Valentova, P. Tvrdy
- 520 9_
- $a AIMS: The effect of polyphenolic fraction of Lonicera caerulea (PFLC) and alkaloid fraction of Macleaya cordata (AFMC) mix on the production of inflammatory mediators in human gingival fibroblasts pretreated with lipopolysaccharide (LPS) was investigated. In addition, protective effects of mucoadhesive paste containing combination of PFLC and AFMC (0.05% and 0.01%, respectively; n=15, Group A) and placebo (n=15, Group B) were evaluated in patients after surgical extraction of lower third molars. METHODS: Gingival fibroblasts were pre-treated with LPS (10 μg/mL; 24 h) and PFLC/AFMC (25/0.25; 50/0.25; 100/0.25; 25/0.5; 50/0.5; 100/0.5 μg/mL) in serum-free medium was applied for 4 h. Then the interleukin-6 (IL-6), reactive oxygen species (ROS) generation, level of intracellular glutathione (GSH) and expression of cyclooxygenase-2 (COX-2) were evaluated. The study was a 6-day, single-center, randomized, double-blind and placebo-controlled trial consisting of two parallel treatment arms. A modified Oral health impact profile questionnaire including both general oral condition and extraction related questions, was used to evaluate the oral condition and other changes before (day 0) and on the days 1, 3 and 6 after surgical extraction. RESULTS AND CONCLUSION: The combination of PFLC with AFMC caused a reduction of ROS generation, reduced IL-6 production and suppressed the expression of COX-2. In group A the paste treatment contributed to improvement of oral health-related quality of life. Topical application of PFLC and AFMC into the extraction wound improved post-extraction site wound healing probably by antioxidant and anti-inflammatory mechanisms.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $x farmakologie $7 D017382
- 650 12
- $a molár třetí $x chirurgie $x metabolismus $7 D008964
- 650 _2
- $a interleukin-6 $7 D015850
- 650 _2
- $a lipopolysacharidy $x farmakologie $7 D008070
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a cyklooxygenasa 2 $x farmakologie $7 D051546
- 650 _2
- $a fenoly $x farmakologie $7 D010636
- 650 _2
- $a hojení ran $7 D014945
- 650 12
- $a alkaloidy $x farmakologie $7 D000470
- 650 _2
- $a fibroblasty $x metabolismus $7 D005347
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Galandáková, Adéla, $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1979- $7 stk2008428623
- 700 1_
- $a Valentová, Kateřina, $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic $d 1976- $7 xx0034397
- 700 1_
- $a Tvrdý, Peter, $u Department of Oral and Maxillofacial Surgery, University Hospital, Olomouc, Czech Republic $d 1972- $7 xx0159584
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 2 (2023), s. 131-138
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34617520 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230807083253 $b ABA008
- 999 __
- $a ok $b bmc $g 1964372 $s 1195217
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 167 $c 2 $d 131-138 $e 20211006 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK198 $a Pubmed-20230707